ArticleBreast cancer research : BCR2025

CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer.

Qianfeng Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.